Achdiat Pati Aji, Pranata Safira Mitayani, Maharani Retno Hesty
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran - Dr. Hasan Sadikin Hospital, Bandung, West Java, Indonesia.
Clin Cosmet Investig Dermatol. 2025 May 19;18:1225-1230. doi: 10.2147/CCID.S515703. eCollection 2025.
Anogenital warts (AGW) are benign proliferative diseases caused by human papillomaviruses (HPV), characterized by verrucous papules on the genital or anal region In line with these findings, the prevalence of AGW is high among males and increasing in Indonesia, and most patients seek treatment because warts are cosmetically disfiguring and itchy. Self-applied treatments may cause local adverse effects such as irritation or burning. Oral and topical administration of glycyrrhizinic acid (Gly) has been observed to have antiviral and anticancer properties.
A 21-year-old immunocompetent patient presented with multiple verrucous lesions on the anal region. Histopathological results showed condyloma acuminate type of AGW, and polymerase chain reaction results showed HPV type 11. The patient was treated with a combination of 10 mL oral Gly thrice daily and self-applied topical Gly three to four pumps thrice daily. The lesions gradually resolved after the first week of the combination of treatments. Subsequently, after 12 weeks of treatment, the wart decreased to one verrucous lesion, and the patient showed no adverse effects.
Gly exhibited broad-spectrum antiviral effects against HPV, herpesviruses, hepatitis viruses, and others. Oral and topical applications are considered safer than intravenous administration. Previous studies on Gly-based topical treatment showed effectiveness in the treatment of AGW with minimal side effects. Oral Gly supplements also have been found to enhance immune response and aid in HPV treatment, particularly when combined with topical Gly. According to the results, a combination of oral and topical Gly leads to high HPV clearance rates, making it a promising non-invasive treatment option.
The combination of topical and oral Gly appears to be a promising self-applied treatment of AGW. However, the potential for recurrence warrants further observation and long-term follow-up studies.
肛门生殖器疣(AGW)是由人乳头瘤病毒(HPV)引起的良性增生性疾病,其特征为生殖器或肛门区域出现疣状丘疹。根据这些研究结果,AGW在印度尼西亚男性中的患病率较高且呈上升趋势,大多数患者寻求治疗是因为疣体影响美观且伴有瘙痒。自行使用的治疗方法可能会引起局部不良反应,如刺激或灼痛。已观察到口服和局部应用甘草酸(Gly)具有抗病毒和抗癌特性。
一名21岁免疫功能正常的患者,肛门区域出现多个疣状病变。组织病理学结果显示为尖锐湿 疣型AGW,聚合酶链反应结果显示为HPV 11型。患者接受治疗,每日口服10 mL Gly,每日三次,同时自行局部应用Gly,每日三次,每次三到四泵。联合治疗第一周后,病变逐渐消退。随后,经过12周的治疗,疣体减少至一个疣状病变,且患者未出现不良反应。
Gly对HPV、疱疹病毒、肝炎病毒等具有广谱抗病毒作用。口服和局部应用被认为比静脉给药更安全。先前关于基于Gly的局部治疗的研究表明,其在治疗AGW方面有效且副作用最小。还发现口服Gly补充剂可增强免疫反应并有助于HPV治疗,特别是与局部应用Gly联合使用时。根据结果,口服和局部应用Gly联合使用可导致较高的HPV清除率,使其成为一种有前景的非侵入性治疗选择。
局部和口服Gly联合应用似乎是一种有前景的AGW自行治疗方法。然而,复发的可能性需要进一步观察和长期随访研究。